IJT - ETF AI Analysis
Top Page
iShares S&P Small-Cap 600 Growth ETF (IJT)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year, helped by solid returns from several of its top holdings.
Broad Sector Diversification
The fund spreads its investments across many sectors, including industrials, technology, health care, and financials, which helps reduce the impact of weakness in any single industry.
Relatively Low Expense Ratio
The ETF’s expense ratio is modest for an actively traded small-cap growth fund, allowing more of the fund’s returns to stay in investors’ pockets.
Negative Factors
Heavy U.S. Market Focus
With almost all assets in U.S. companies, the fund offers little geographic diversification and is highly sensitive to the U.S. economy and market conditions.
Small-Cap Growth Volatility
Because the ETF targets smaller, growth-oriented companies, its share price can be more volatile and sensitive to changes in investor sentiment than funds focused on larger, more established firms.
Concentration in Top Sectors
A large portion of the portfolio is concentrated in industrials, technology, health care, and financials, which could hurt performance if these key sectors weaken.
IJT vs. SPDR S&P 500 ETF (SPY)
AUM7.95B
RegionNorth America
Expense Ratio0.18%
Beta0.95
IssueriShares
Inception DateJul 24, 2000
Dividend Yield0.77%
Asset ClassEquity
Index TrackedS&P Small Cap 600 Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume219,431
30 Day Avg. Volume226,949
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
209.97Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering349
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IJT Summary
IJT is the iShares S&P Small-Cap 600 Growth ETF, which follows the S&P SmallCap 600 Growth Index. It invests in many smaller U.S. companies that are growing quickly, across areas like technology, healthcare, and industrials. Examples of companies in the fund include ViaSat and Corcept Therapeutics. Someone might invest in IJT to seek long-term growth and to diversify beyond large, well-known stocks by adding a wide mix of small, fast-growing businesses. A key risk is that small-cap growth stocks can be more volatile, so the ETF’s price can rise and fall sharply with the market.
How much will it cost me?The iShares S&P Small-Cap 600 Growth ETF (IJT) has an expense ratio of 0.18%, meaning you’ll pay $1.80 per year for every $1,000 invested. This is lower than the average for actively managed funds because IJT is passively managed, tracking the S&P SmallCap 600 Growth Index to keep costs down.
What would affect this ETF?The iShares S&P Small-Cap 600 Growth ETF (IJT) could benefit from economic growth and innovation in sectors like technology and healthcare, which are key drivers of small-cap companies. However, it may face challenges from rising interest rates or economic slowdowns, which can negatively impact smaller firms with higher volatility. Regulatory changes or shifts in consumer demand could also influence the performance of its top holdings and sector exposure.
IJT Top 10 Holdings
IJT is powered by a lively mix of U.S. small-cap growth names, with biotech players like Corcept Therapeutics and Protagonist Therapeutics doing much of the heavy lifting as their shares keep rising. Consumer-focused Brinker International has also been a steady engine, while Etsy is losing steam as profitability concerns weigh on sentiment. ViaSat and Armstrong World show more mixed, stop-and-go performance, limiting upside. Overall, the fund leans into health care and tech-oriented growth stories, all firmly rooted in the U.S. small-cap arena.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Corcept Therapeutics | 1.28% | $99.29M | $12.09B | 48.72% | 76 Outperform | |
| ViaSat | 1.15% | $89.57M | $9.77B | 119.25% | 56 Neutral | |
| Brinker International | 1.08% | $83.96M | $8.80B | 45.88% | 70 Neutral | |
| Protagonist Therapeutics | 1.03% | $80.26M | $9.24B | 141.20% | 68 Neutral | |
| Ryman | 0.98% | $76.03M | $8.18B | 24.33% | 66 Neutral | |
| Formfactor | 0.98% | $75.95M | $8.19B | 190.84% | 68 Neutral | |
| Alkermes | 0.92% | $71.37M | $7.73B | 65.30% | 80 Outperform | |
| TG Therapeutics | 0.88% | $68.42M | $8.55B | 74.31% | 65 Neutral | |
| StoneX Group | 0.86% | $66.53M | $8.15B | 61.41% | 58 Neutral | |
| Madison Square Garden Sports | 0.85% | $65.83M | $9.48B | 83.24% | 45 Neutral |
IJT Technical Analysis
Negative
―
Price Trends
171.80
Negative
168.73
Negative
158.34
Positive
Market Momentum
-2.69
Positive
28.90
Positive
15.90
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IJT, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 168.28, equal to the 50-day MA of 171.80, and equal to the 200-day MA of 158.34, indicating a neutral trend. The MACD of -2.69 indicates Positive momentum. The RSI at 28.90 is Positive, neither overbought nor oversold. The STOCH value of 15.90 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IJT.
IJT Peer Comparison
Comparison Results
Performance Comparison
IJT
iShares S&P Small-Cap 600 Growth ETF
163.01
22.04
15.63%
FNDA
Schwab Fundamental US Small Co. Index ETF
―
―
―
SLYG
SPDR S&P 600 Small Cap Growth ETF
―
―
―
VTWG
Vanguard Russell 2000 Growth ETF
―
―
―
FYC
First Trust Small Cap Growth AlphaDEX Fund
―
―
―
VIOG
Vanguard S&P Small-Cap 600 Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents